HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme Renagel Inventory Stable By 2003; Wholesaler Agreements Planned

Executive Summary

Genzyme will use formal agreements with wholesalers to draw down excess Renagel inventory levels by the beginning of 2003, Renagel General Manager John Butler said during a conference call to announce revised earnings estimates Sept. 16
Advertisement

Related Content

Genzyme Renagel Growth To Come From Medicare Rx, Kidney Disease Use
Genzyme Renagel Growth To Come From Medicare Rx, Kidney Disease Use
Genzyme Renagel Margin Improves As Private Contracts Grow
Genzyme Renagel Margin Improves As Private Contracts Grow
Wholesaler Task Force Looking At Shortages, Forward-Buying
Wholesaler Task Force Looking At Shortages, Forward-Buying
Genzyme Renagel Margins To Exceed 70% Following Manufacturing Upgrades
Genzyme Renagel Margins To Exceed 70% Following Manufacturing Upgrades
Advertisement
UsernamePublicRestriction

Register

PS040502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel